Skip to main navigation
Prelude Therapeutics
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • SMARCA2
    • CDK9
    • Precision ADCs
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT3789 Trials
    • PRT2527 Trials
    • PRT7732 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
      • SMARCA Educational Video Series
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • SMARCA2
    • CDK9
    • Precision ADCs
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT3789 Trials
    • PRT2527 Trials
    • PRT7732 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
      • SMARCA Educational Video Series
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact

Document Details

Form
EFFECT
Filing Date
May 8, 2024
Document Date
May 8, 2024
Form Description
EFFECT
Filing Group
Other
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
RSS Feeds
Email Alerts
Search
preludetx.com

© Prelude Therapeutics
200 Powder Mill Road
Wilmington, DE 19803
(302) 467-1280

  • About
  • Science
  • Clinical Trials
  • Investors
  • News
  • Life at Prelude
  • Contact
visit our Twitter page visit our LinkedIn page Terms of Use Privacy Policy
logo
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • SMARCA2
    • CDK9
    • Precision ADCs
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT3789 Trials
    • PRT2527 Trials
    • PRT7732 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
      • SMARCA Educational Video Series
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact